Literature DB >> 29541950

Impact of early systemic lupus erythematosus on work disability-results from the Finnish nationwide register 2000-2007.

Pia Elfving1, Kari Puolakka2, Vappu Rantalaiho3,4, Hannu Kautiainen5,6,7, Lauri J Virta8, Oili Kaipiainen-Seppänen9.   

Abstract

Objectives of this study were to examine work disability (WD) and its leading causes in incident SLE patients. Data were derived from the Finnish nationwide registries to identify all non-retired, 18 to 64-year-old incident SLE patients between 2000 and 2007. Sick benefits and WD pensions and the causes for them were monitored until the end of 2008. A total of 446 working-aged, incident SLE patients available for work force (mean age 42 ± 13 years, 89% females) were found. During the follow-up (median 5.3 years), WD pension was granted to 27 patients. The most common cause was SLE itself (14 patients, 52%), with cumulative incidence of 3.4% (95% CI 1.9 to 5.8) in 5 years and 5.0% (95% CI 3.0 to 8.5) in 8 years, followed by musculoskeletal and psychiatric causes. The age- and sex- adjusted incidence ratio for WD pension in SLE patients due to any cause was 5.4 (95% CI 3.7 to 7.9) compared to the Finnish population. The mean number of WD days was 32 (95% CI 28 to 35) per patient-year among all SLE patients during the follow-up. The study concludes that SLE patients have an increased risk for WD already in early course of the disease.

Entities:  

Keywords:  Insurance benefits; Pensions; Registries; Systemic lupus erythematosus; Work disability

Mesh:

Year:  2018        PMID: 29541950     DOI: 10.1007/s10067-018-4066-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  19 in total

Review 1.  Epidemiology of connective tissue disorders.

Authors:  M Gaubitz
Journal:  Rheumatology (Oxford)       Date:  2006-10       Impact factor: 7.580

2.  Education, employment, absenteeism, and work disability in women with systemic lupus erythematosus.

Authors:  S Ekblom-Kullberg; H Kautiainen; P Alha; M Leirisalo-Repo; H Julkunen
Journal:  Scand J Rheumatol       Date:  2014-10-29       Impact factor: 3.641

3.  Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres.

Authors:  A Zink; R Fischer-Betz; K Thiele; J Listing; D Huscher; E Gromnica-Ihle; C Specker; M Schneider
Journal:  Lupus       Date:  2004       Impact factor: 2.911

4.  The impact of systemic lupus erythematosus on employment.

Authors:  Robert Campbell; Glinda S Cooper; Gary S Gilkeson
Journal:  J Rheumatol       Date:  2009-02-27       Impact factor: 4.666

5.  Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort.

Authors:  Jinoos Yazdany; Edward H Yelin; Pantelis Panopalis; Laura Trupin; Laura Julian; Patricia P Katz
Journal:  Arthritis Rheum       Date:  2008-01-15

6.  Work disability in systemic lupus erythematosus is prevalent and associated with socio-demographic and disease related factors.

Authors:  K Baker; J Pope; P Fortin; E Silverman; C Peschken
Journal:  Lupus       Date:  2009-10-23       Impact factor: 2.911

7.  Correlates of formal work disability in an urban university systemic lupus erythematosus practice.

Authors:  Tammy O Utset; Saima Chohan; Stephanie A Booth; Janelle C Laughlin; Masha Kocherginsky; Amanda Schmitz
Journal:  J Rheumatol       Date:  2008-05-01       Impact factor: 4.666

Review 8.  Employment and work disability in systemic lupus erythematosus: a systematic review.

Authors:  Kim Baker; Janet Pope
Journal:  Rheumatology (Oxford)       Date:  2009-01-19       Impact factor: 7.580

9.  Work disability in systemic lupus erythematosus.

Authors:  Ali M Al Dhanhani; Monique A M Gignac; Jiandong Su; Paul R Fortin
Journal:  Arthritis Rheum       Date:  2009-03-15

10.  Risk and predictors of work disability in Chinese patients with systemic lupus erythematosus.

Authors:  C C Mok; M Y Cheung; L Y Ho; K L Yu; C H To
Journal:  Lupus       Date:  2008-12       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.